Anatara Lifesciences Ltd

ASX:ANR ISIN:AU000000ANR0

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see http://www.anataralifesciences.com for further background.

     

News

Anatara Lifesciences Ltd (ASX:ANR) Presents at Australasian Pig Science Association Conference

🕔11/21/2017 3:38:26 PM 940

At the Australasian Pig Science Association Conference in Melbourne this week, Dr Trish Holyoake & Dr Tracey Mynott presented a poster highlighting the comparable efficacy of a single dose of Anatara's (ASX:ANR) Detach(R) product to in-feed Zinc oxide in reducing diarrhoea and antibiotic treatments in post-weaning piglets.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Chairman's Address to Shareholders

🕔11/13/2017 11:44:04 AM 967

Anatara Lifesciences Ltd (ASX:ANR) provides the Chairman's address to shareholders.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Dr Tracey Mynott Presents at TRI Science Business Inspiration Series

🕔11/3/2017 12:11:11 PM 1308

Anatara Lifesciences (ASX:ANR) CSO, Dr Tracey Mynott, was recently invited to present at the Translational Research Institute's Science Business Inspiration Series. The series was launched with Session 1 "The whole journey: from idea to reality".

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔10/18/2017 8:24:01 AM 1220

Anatara Lifesciences (ASX:ANR) is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO & Chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Annual Report 2017 Update

🕔10/4/2017 1:02:46 PM 1588

Anatara Lifesciences Ltd (ASX:ANR) provides the Company's Annual Report 2017 Update.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Pork CRC Options Extended by 12 Months

🕔9/13/2017 9:36:01 AM 1767

Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre in 2015.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) and Zoetis to Negotiate Terms of International Detach(R) Commercial Agreement

🕔8/21/2017 8:55:23 AM 1931

Anatara Lifesciences Ltd (ASX:ANR) is pleased to announce that global animal health company, Zoetis Inc. has exercised its option to negotiate a commercial agreement for the worldwide development, distribution and marketing of Detach(R), with terms to be agreed.

Read Full Article

FINANCE VIDEO: Anatara Lifesciences Ltd (ASX:ANR) Gold Coast Investment Showcase Investor Presentation

🕔6/21/2017 2:07:56 PM 4218

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation for the Gold Coast Investment Showcase (June 21st & 22nd 2017).

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Wilsons Equity Research Report Issued with Buy Rating

🕔6/8/2017 10:30:52 AM 2113

Wilsons maintain a BUY rating and $1.66 price target. Anatara's recent stock underperformance has simply reflected a slow quarter for news in the lead-up to a significant inflection point in the 2H.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Update and R&D Tax Rebate

🕔6/6/2017 8:24:57 AM 2420

Anatara Lifesciences Ltd (ASX:ANR) is pleased to provide investors with an update on recent progress.

Read Full Article
###

15,010 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 952) (Last 30 Days: 2226) (Since Published: 15010) 

Markets ASX:ANR

Company Data

    Headquarters
  • 433 Logan Road, Stones Corner
    Brisbane, Queensland 4120
    Australia
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.anataralifesciences.com
  • E:
  • info@anataralifesciences.com

Company Reports

Presentations

Research Report

Social Media